White Paper－The Vigiis 101-LAB, provides bodywide microbiome benefits with just one ingredient
This white paper will expose the remaining untapped market potential for probiotics, as well as the role Vigiis® 101-LAB can play in meeting consumer needs for complete probiotic support across the microbiome.
• USD $78.3 billion will be reached by global probiotics market in 2026
• Constipation affecting 16% of US adults and 33% of US seniors
• COVID-19 has rocketed sales of immune health supplements up 25 percent in 2020, with expected impact in probiotics.